Skip to Main Content

Advertisement

Close

AACR Journals
For Authors
About Us
Article Collections
COVID-19
Webinars

header search

search input Search input auto suggest

Search

Advanced Search

Menu

About
Articles
For Authors
Alerts
News
COVID-19
Webinars

Skip Nav Destination

Issues

Select Year

Issue

Volume 4, Issue 6

1 June 1998

Front Matter
Table of Contents
Back Matter
Editorial Board

ISSN 1078-0432

EISSN 1557-3265

Issue Sections

Advances in Brief
Research Articles

Advances in Brief

Monitoring of p53 autoantibodies in lung cancer during therapy: relationship to response to treatment.

G Zalcman; B Schlichtholz; J Trédaniel; T Urban; R Lubin; I Dubois; B Milleron; A Hirsch; T Soussi

Improved targeting of brain tumors using dexrazoxane rescue of topoisomerase II combined with supralethal doses of etoposide and teniposide.

B Holm; M Sehested; P B Jensen

Research Articles

Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis.

H Porte; J P Triboulet; L Kotelevets; F Carrat; S Prévot; B Nordlinger; Y DiGioia; A Wurtz; P Comoglio; C Gespach; E Chastre

Epidermal growth factor receptor expression in cervical intraepithelial neoplasia and its modulation during an alpha-difluoromethylornithine chemoprevention trial.

I V Boiko; M F Mitchell; W Hu; D K Pandey; P Mathevet; A Malpica; W N Hittelman

The expression of drug resistance gene products during the progression of human prostate cancer.

G F Sullivan; P S Amenta; J D Villanueva; C J Alvarez; J M Yang; W N Hait

4-(3'-Bromo-4'hydroxylphenyl)-amino-6,7-dimethoxyquinazoline: a novel quinazoline derivative with potent cytotoxic activity against human glioblastoma cells.

R K Narla; X P Liu; D E Myers; F M Uckun

Analysis of DNA mismatch repair proteins in human medulloblastoma.

S E Lee; S P Johnson; L P Hale; J Li; N Bullock; H Fuchs; A Friedman; R McLendon; D D Bigner; P Modrich; H S Friedman

Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia.

P C Caron; L Dumont; D A Scheinberg

Renal clearance, tissue distribution, and CA-125 responses in a phase I trial of suramin.

P R Hutson; K D Tutsch; R Rago; R Arzoomanian; D Alberti; M Pomplun; D Church; R Marnocha; A L Cheng; N Kehrli; G Wilding

Phase I study of 9-cis-retinoic acid (ALRT1057 capsules) in adults with advanced cancer.

N A Rizvi; J L Marshall; E Ness; J Yoe; G M Gill; J A Truglia; G R Loewen; D Jaunakais; E H Ulm; M J Hawkins

Dose escalation of the hypoxic cell sensitizer etanidazole combined with ifosfamide, carboplatin, etoposide, and autologous hematopoietic stem cell support.

A D Elias; C Wheeler; L J Ayash; G Schwartz; J Ibrahim; L Mills; M McCauley; N Coleman; D Warren; L Schnipper; K H Antman; B A Teicher; E Frei, 3rd

Phase II study of dexverapamil plus anthracycline in patients with metastatic breast cancer who have progressed on the same anthracycline regimen.

E Warner; D Hedley; I Andrulis; R Myers; M Trudeau; D Warr; K I Pritchard; M Blackstein; P E Goss; E Franssen; K Roche; S Knight; S Webster; R A Fraser; S Oldfield; W Hill; R Kates

A phase I and translational study of sequential administration of the topoisomerase I and II inhibitors topotecan and etoposide.

L A Hammond; J R Eckardt; R Ganapathi; H A Burris; G A Rodriguez; S G Eckhardt; M L Rothenberg; G R Weiss; J G Kuhn; S Hodges; D D Von Hoff; E K Rowinsky

Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with 5-fluorouracil and cis-platinum.

N Boku; K Chin; K Hosokawa; A Ohtsu; H Tajiri; S Yoshida; T Yamao; H Kondo; K Shirao; Y Shimada; D Saito; T Hasebe; K Mukai; S Seki; H Saito; P G Johnston

Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis.

K Mise; S Tashiro; S Yogita; D Wada; M Harada; Y Fukuda; H Miyake; M Isikawa; K Izumi; N Sano

Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma.

T Shibusa; N Shijubo; S Abe

Prognostic value of prostate-specific antigen for women with breast cancer: a large United States cohort study.

H Yu; M A Levesque; G M Clark; E P Diamandis

p21waf1/cip1 and transforming growth factor beta 1 protein expression correlate with survival in non-small cell lung cancer.

W P Bennett; W S el-Deiry; W L Rush; D G Guinee, Jr; A N Freedman; N E Caporaso; J A Welsh; R T Jones; A Borkowski; W D Travis; M V Fleming; V Trastek; P C Pairolero; H D Tazelaar; D Midthun; J R Jett; L A Liotta; C C Harris

Motility related protein 1 (MRP1/CD9) expression in colon cancer.

M Mori; K Mimori; T Shiraishi; M Haraguchi; H Ueo; G F Barnard; T Akiyoshi

Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer.

J Kos; H J Nielsen; M Krasovec; I J Christensen; N Cimerman; R W Stephens; N Brünner

Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias.

K Sonoda; T Kaku; T Kamura; M Nakashima; T Watanabe; H Nakano

CD28, a marker associated with tumoral expansion in multiple myeloma.

N Robillard; G Jego; C Pellat-Deceunynck; D Pineau; D Puthier; M P Mellerin; S Barillé; M J Rapp; J L Harousseau; M Amiot; R Bataille

Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.

T Yamada; S Nakamori; H Ohzato; S Oshima; T Aoki; N Higaki; K Sugimoto; K Akagi; Y Fujiwara; I Nishisho; M Sakon; M Gotoh; M Monden

Quantitative reverse transcriptase-polymerase chain reaction measured expression of MDR1 and MRP in primary breast carcinoma.

D W Dexter; R K Reddy; K G Geles; S Bansal; M A Myint; A Rogakto; J C Leighton; L J Goldstein

Flow cytometric DNA analyses of benign breast lesions detected by screening mammography.

P C Stomper; J R DeBloom, 2nd; R M Budnick; C C Stewart

Differential permeability of a human brain tumor xenograft in the nude rat: impact of tumor size and method of administration on optimizing delivery of biologically diverse agents.

E A Neuwelt; P A Barnett; C I McCormick; L G Remsen; R A Kroll; G Sexton

The growth inhibitory effect of N1,N12-bis(ethyl)spermine in small cell lung cancer cells is maintained in cells expressing the c-myc and Ha-ras oncogenes.

L F Barr; S E Campbell; P Tamez; R A Casero, Jr

Potential interactions between antitubulin agents and temperature: implications for modulation of multidrug resistance.

C Dumontet; F Bodin; Y Michal

Efficacy of pyridoxine to ameliorate the cutaneous toxicity associated with doxorubicin containing pegylated (Stealth) liposomes: a randomized, double-blind clinical trial using a canine model.

D M Vail; R Chun; D H Thamm; L D Garrett; A J Cooley; J E Obradovich

Telomerase activity of sarcoma cell lines and fibroblasts is independent of p53 status.

M Milas; D Yu; D Sun; R E Pollock

Advertisement

Email alerts

Online First Alert

eTOC Alert

Latest
Most Read
Most Cited

Pertuzumab, Trastuzumab, and an Aromatase Inhibitor for HER2-Positive and Hormone Receptor-Positive Metastatic/Locally Advanced Breast Cancer: PERTAIN Final Analysis

NPY methylated ctDNA is a promising biomarker for treatment response monitoring in metastatic colorectal cancer

CEACAM1 marks highly suppressive intratumoral regulatory T cells for targeted depletion therapy

Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases

Issues
Online First
Collections

News
Twitter

Online ISSN 1557-3265
Print ISSN 1078-0432

AACR Journals

Blood Cancer Discovery
Cancer Discovery
Cancer Epidemiology, Biomarkers, & Prevention
Cancer Immunology Research
Cancer Prevention Research
Cancer Research
Cancer Research Communications
Clinical Cancer Research
Molecular Cancer Research
Molecular Cancer Therapeutics

Info for Advertisers
Info for Librarians
Privacy Policy

Twitter
LinkedIn
Facebook
Youtube

Copyright © 2022 by the American Association for Cancer Research.

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.

Accept